Fabric Systems Competitors

We’re on a journey to Grow the Future of Materials. How? By unlocking the unique properties of mycelium, the root structure of mushrooms. Our patented technology, Fine Mycelium™, unleashes a new class of materials crafted from nature, engineered for performance, and built for a resilient future. Our impact on future generations steers our innovations today. From our expertise in mycology and materials science to our manufacturing innovations, we’re creating new possibilities for industry. We’re an outstanding team of scientists, engineers, product experts, artists, leaders—and you.

AETHER (pronounced “ē-ther”) was started in 2009 when founders Palmer West and Jonah Smith were inspired to create something they couldn’t find. They were city dwellers with a passion for the outdoors, businessmen who wanted outerwear that supported their lifestyle without making them look like they were in a lift line. AETHER was born out of the desire for a men’s collection that looked at home in the city but was built to withstand the outdoors. Today, AETHER is a complete lifestyle collection for urban-dwelling, design-focused, well-traveled men and women. The company is headquartered on Melrose Avenue in Los Angeles, just blocks away from its flagship store on La Brea Avenue. Other retail locations include San Francisco, Aspen, and Jackson Hole.

Tissue Regenix is a leading medical devices company in the field of regenerative medicine. Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds, UK. The company's patented decellularisation ('dCELL®') technology removes DNA and other cellular material from animal and human soft tissue leaving an acellular tissue scaffold which is not rejected by the patient's body and can then be used to repair diseased or worn out body parts. Current applications address many critical clinical needs such as sports medicine, heart valve replacement and wound care. In November 2012 Tissue Regenix Group plc set up a subsidiary company in the United States - 'Tissue Regenix Wound Care Inc.', rebranded 'TRX BioSurgery' in February 2018. January 2016 saw the establishment of joint venture GBM-V, a multi- tissue bank based in Rostock, Germany. In August 2017 Tissue Regenix acquired CellRight Technologies®, a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteoinductive and wound care scaffolds that enhance healing opportunities of defects created by trauma and disease. CellRight's human osteobiologics may be used in spine, trauma, general orthopedic, foot & ankle, dental, and sports medicine surgical procedures.